Lupus refractory pleural effusion: transient response to intravenous immunoglobulins.
A patient with systemic lupus erythematosus complicated by refractory bilateral pleural effusions is described. High dose corticosteroids with azathioprine, as well as intrapleural instillation of corticosteroids, proved ineffective in management. As our patient remained severely symptomatic and required repeated thoracocentesis, a therapeutic trial of intravenous immunoglobulins (IVIG) was attempted. IVIG had a beneficial effect, although of a transient and partial nature. Despite the results achieved, it seems that IVIG has limited value in treating lupus pleural effusion.
Ben-Chetrit
E
E
Department of Internal Medicine A, Hadassah University Hospital, Ein-Kerem, Jerusalem, Israel.
Putterman
C
C
Naparstek
Y
Y
D000328:Adult; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007116:Immunization, Passive / Q000592:standards; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D008168:Lung / Q000000981:diagnostic imaging; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy*; D010996:Pleural Effusion / Q000150:complications* / Q000000981:diagnostic imaging / Q000188:drug therapy*; D011859:Radiography
D016756:Immunoglobulins, Intravenous